Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice.

AIMS To determine the effect of grapefruit juice on omeprazole metabolism in vivo. METHODS This was a randomized crossover study with a 2 week washout period. Omeprazole (20 mg) was taken orally by 13 healthy volunteers after an overnight fast with either grapefruit juice or water. Serial blood samples were obtained over 12 h and standardized meals were served 3 and 10 h after the administration of omeprazole. Plasma concentrations of omeprazole and its major metabolites, 5-hydroxyomeprazole and omeprazole sulphone, were determined by high performance liquid chromatography (h.p.l.c.). RESULTS Mean area under the plasma concentration vs time curve (AUC) between 0 and 12 h for omeprazole sulphone was approximately 20% lower (P<0.01) in the group receiving grapefruit juice. There was no significant difference in the mean AUC of 5-hydroxyomeprazole or omeprazole. The AUC ratio of omeprazole sulphone to omeprazole, an index of CYP3A4 activity, was decreased by 33% (P<0.001) after administration of grapefruit juice whereas the AUC ratio of 5-hydroxyomeprazole to omeprazole, an index of CYP2C19 activity, did not differ between the two phases of the study. Although the time to peak concentration (tmax ) and terminal half-life (t1/2,z) of omeprazole and its two main metabolites were not altered, the peak concentration (Cmax ) of omeprazole sulphone was significantly reduced after administration of grapefruit juice. CONCLUSION Administration of grapefruit juice decreased the formation of omeprazole sulphone but not 5-hydroxyomeprazole. These results indicate that activities of CYP3A4, but not of CYP2C19, are inhibited by the simultaneous administration of grapefruit juice.

[1]  P. Watkins,et al.  Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[2]  S. Krähenbühl,et al.  Interaction between grapefruit juice and midazolam in humans , 1995, Clinical pharmacology and therapeutics.

[3]  A. Walan Clinical experience with omeprazole: assessment of efficacy and safety. , 1989, Journal of gastroenterology and hepatology.

[4]  W. Legrum,et al.  The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human , 1997, European Journal of Clinical Pharmacology.

[5]  Y. Oshima,et al.  Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. , 1997, Pharmacogenetics.

[6]  J. Miners,et al.  Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. , 1993, British journal of clinical pharmacology.

[7]  T. Tomson,et al.  Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19. , 2003, British journal of clinical pharmacology.

[8]  R. Benton,et al.  Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram , 1996, Clinical pharmacology and therapeutics.

[9]  J. Miners,et al.  Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism. , 1994, British journal of clinical pharmacology.

[10]  Morton B. Brown,et al.  Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. , 1997, The Journal of clinical investigation.

[11]  L. Bertilsson,et al.  Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19. , 1995, British journal of clinical pharmacology.

[12]  S. Higuchi,et al.  Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, CYP2C19m1 in exon 5 and CYP2C19m2 in exon 4, in Japanese subjects , 1996 .

[13]  T. Hedner,et al.  Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women. , 1994, Maturitas.

[14]  B. Edgar,et al.  Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans , 1991, Clinical pharmacology and therapeutics.

[15]  P. Neuvonen,et al.  Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice , 1995, Clinical pharmacology and therapeutics.

[16]  L. Bertilsson,et al.  Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators. , 1990, Therapeutic drug monitoring.

[17]  C. Regårdh,et al.  Effects of grapefruit juice ingestion – pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men , 1997, European Journal of Clinical Pharmacology.

[18]  K. Chiba,et al.  Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population. , 1992, The Journal of pharmacology and experimental therapeutics.

[19]  D. Bailey,et al.  Grapefruit juice-drug interactions. , 1998, British journal of clinical pharmacology.

[20]  D. Bailey,et al.  Grapefruit juice–felodipine interaction: Mechanism, predictability, and effect of naringin , 1993, Clinical pharmacology and therapeutics.

[21]  Kaoru Kobayashi,et al.  Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed-phase high-performance liquid chromatography with an alkaline-resistant polymer-coated C18 column. , 1992, Journal of chromatography.

[22]  M. Ducharme,et al.  Disposition of intravenous and oral cyclosporine after administration with grapefruit juice , 1995, Clinical pharmacology and therapeutics.

[23]  U. Fuhr,et al.  Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. , 1993, British journal of clinical pharmacology.

[24]  L. Bertilsson,et al.  Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S‐mephenytoin , 1997, Clinical pharmacology and therapeutics.

[25]  L. Pickle,et al.  The hydroxylation of omeprazole correlates with S‐mephenytoin metabolism: A population study , 1995, Clinical pharmacology and therapeutics.